Revolutionary advances in imaging drive discovery in the biomedical sciences. These advances in imaging depend on innovations in technology throughout the physical and biological sciences. In recent decades, a number of significant breakthroughs have underscored the importance of this interdependent relationship between technology and biomedical science. One important discovery that culminated in the 2008 Nobel Prize was the work of Tsien et al. that led to the structure, expression, and optimization of fluorescent proteins for biomedical imaging applications. There have been other key discoveries in the areas of imaging technology, contrast agents and clinical applications. For example, multimodality imaging, including PET/CT and PET/MR, has evolved at a rapid pace, along with development of image fusion technology for combining data sets from multimodal imaging studies obtained at various biological scales, spatial and temporal resolutions. Major advances in multimodality nanoparticle based imaging agents have taken advantage of the myriad of imaging platforms, from microscopy to MRI and PET. Hyperpolarized 13C MR in concert with simultaneous 11C PET employing state-of-the-art PET/MR scanners promises a revolution in preclinical and clinical molecular imaging. Advances in optical techniques have continued a rapid pace with most recently, super resolution microscopy (Nobel Prize in chemistry, 2014), and optogenetics (Keio Medical Science Prize, 2014) revolutionizing the biological sciences. What are the challenges and frontier domains of imaging sciences in the 21st century? The following examples describe challenges that are interconnected with advances in basic and translational sciences. (1) With progress in cell therapy and tissue engineering, noninvasive imaging of stem cells will be needed to ascertain delivery to target sites. (2) More hybrid imaging systems will be developed, such as PET and optical or photoacoustic imaging. (3) Nanoparticles with multimodality imaging capabilities and drug payloads will be optimized and moved into clinical trials. These challenges must be met by interdisciplinary teams of engineers, physicists, computer scientists, mathematicians, chemists, biologists, and physicians working together at the interfaces between biology, technology, and medicine to develop new imaging technologies, modalities, and applications. Washington University therefore launched the Imaging Sciences Pathway (ISP), initially through a T90-R90 Roadmap Initiative grant through 2010. This proposal requests continued support under a broad-based T32 mechanism for the interdisciplinary training of predoctoral students in our Imaging Sciences Pathway.
Biomedical imaging is key to unlocking the secrets of human health and disease, from the level of genes and proteins, to signaling pathways, to cells and tissues, and whole organisms--and ultimately to visualizing the effectiveness of therapies in action. The better imaging tools we develop, the greater our ability to treat disease and improve human health. To this end, the training of interdisciplinary imaging scientists is critical.
Showing the most recent 10 out of 40 publications
